ARCHIVES

In Brief: Doug Ulman named CEO of Pelotonia

This article is from The Cancer Letter archive.

Vol. 40 No. 36 | September 26, 2014

Download PDF Visit The Full Archive

Related Articles

Natcher Subcommittee Open Door To justification for Increasing Cancer Program 1982 Appropriation

April 3, 1981

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

DCE Advisors OK Recompetitions Worth $10 Mil.

July 19, 1991

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991

FDA Issues Final Rules On Patient Access To Investigational Drugs

September 11, 2009

Amgen Agrees To Buy Immunex For $16 Billion In Stock And Cash.

January 25, 2002